JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to.
Ligand Pharma (LGND) Launches Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMItm lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: Immun .
DGAP-News: Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US
vom 17.12.2020, 09:00 Uhr
Bild: pixabay.com
DGAP-News: Immune Regulation Limited / Key word(s): Personnel
Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US
17.12.2020 / 09:00
The issuer is solely responsible for the content of this announcement.
Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US
(London UK, New Orleans US, 17 December, 2020) Immune Regulation Ltd, a US and UK based clinical stage biotechnology company announced today a series of appointments to build out the Board and leadership team that will work alongside Jonathan Rigby, Group CEO of Immune Regulation, in advancing the development of its fir